Viewing Study NCT06742502


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2025-12-26 @ 2:21 AM
Study NCT ID: NCT06742502
Status: RECRUITING
Last Update Posted: 2025-06-05
First Post: 2024-12-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL
Sponsor: Sun Yat-sen University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-11-12
Start Date Type: ACTUAL
Primary Completion Date: 2027-12-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-12-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-12-07
First Submit QC Date: None
Study First Post Date: 2024-12-19
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-04
Last Update Post Date: 2025-06-05
Last Update Post Date Type: ACTUAL